Retatrutide

Retatrutide is an investigational triple-receptor agonist designed to target GLP-1, GIP, and glucagon receptors. From a research perspective, it is especially valuable because it allows scientists to examine how simultaneous activation of satiety, insulin-regulatory, and energy-expenditure pathways may affect metabolic outcomes. GLP-1 and GIP signaling are associated with appetite and glucose regulation, while glucagon receptor activity is studied for its potential role in energy expenditure, lipid handling, and liver metabolism. Retatrutide is frequently discussed in next-generation obesity and metabolic research because it represents a broader multi-hormone approach.